We are looking for young people 2–17 years of age to join a Crohn’s disease (CD) trial to help us discover more about treating moderately to severely active IBD. If you are looking for a potential new treatment option for moderately to severely active IBD or moderate to severe Crohn’s disease (including associated symptoms such as painful joints, fatigue, constant need to poop, frequent fevers and/or anemia), consider one of our clinical research. All eligible participants will receive no-cost study-related care and study medication. Your child or teen 2–17 years of age may be eligible to take part.
Your child may be eligible to take part in the clinical research if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Is your child eligible?
